$195.39
-7.71-3.8%
Últ. Act.: Sep 23, 11:47 AM
Axsome Therapeutics Inc
AXSMNASDAQ
Axsome Therapeutics Earnings & Forecasts
Axsome Therapeutics (AXSM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Axsome Therapeutics Guidance
Axsome Therapeutics (AXSM) publicó su última previsión de enero 4, 2024 para fiscal year 2023. La compañía estimó ingresos en un rango de $204M - $204M para el período.
En comparación con la previsión anterior, Axsome Therapeutics elevado redujo su previsión de ingresos desde un rango anterior de $71M - $71M.
Axsome Therapeutics ha emitido 2 actualizaciones de orientación entre el enero 4, 2024 y el enero 4, 2024. During this period, the company raised its outlook 1 time, reflecting management's growing confidence in business performance.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.87 | $-0.83 | $-0.72 | $-0.87 |
| Actual | $-0.99 | $-1.26 | $-0.56 | $-0.68 |
| Surprise | -13.8% | -51.8% | +22.2% | +21.8% |
| Revenue | ||||
| Estimate | $222.3M | $190.3M | $193.2M | $163.4M |
| Actual | $218.4M | $191.2M | $196.0M | $171.0M |
| Surprise | -1.77% | +0.48% | +1.47% | +4.64% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.48 | $0.05 | $-0.08 | $0.49 |
| Revenue | ||||
| Consensus | $257.7M | $297.3M | — | — |